Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The phase II study demonstrated that once-weekly subcutaneous dosing of CT-388 can lead to substantial placebo-adjusted weight loss at 48 weeks, with participants continuing to lose weight without reaching a plateau
Injection site redness can happen to anyone receiving an injectable medication but is most common when a medication is given subcutaneously
These techniques significantly reduce bruising in most patients
As this mesh starts to dissolve, the drug is gradually released
Its a case by case assessment of do the benefits outweigh the potential risk? she says
Conditions like gastroparesis , a disorder that affects stomach muscle function and delays stomach emptying, may worsen with GLP-1 use
US$ 27.17
US$ 28.33
US$ 29.44
US$ 26.92
